Lung health in patients with severe brain bleed
Part of Brain & nervous system, Heart & circulation, Lungs & breathing clinical trials.
This trial looks at how a severe brain bleed (subarachnoid hemorrhage) might affect lung function and hyaluronic acid buildup in the lungs. It aims to find better ways to protect breathing for patients in the intensive care unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with a subarachnoid hemorrhage (brain bleed) within the last 5 days.
- Your condition is rated as Grade 4 or 5 on the Hunt-Hess scale (severe).
- You do not have signs of a lung infection now.
- You are not pregnant or breastfeeding.
- You have not had a head injury or a lung infection in the past 6 months, and you do not have cancer, chronic heart or lung disease, blood disorders, or kidney failure.
- You have not been in another clinical trial in the past 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is observing people who have had a brain bleed that happened on its own (not from an injury). It aims to track their health outcomes and understand how to improve care for future patients.
This trial tests whether a special mouth rinse and preventive antibiotics can lower the risk of pneumonia after a brain bleed (intracerebral hemorrhage). If you've had a small bleed in the upper part of the brain and are at risk for pneumonia, this study may help.
This study follows people with a brain bleed from a ruptured aneurysm in real-world hospital settings. It aims to better understand delayed brain damage after the bleed, which could help improve care.
This study looks at how a brain bleed can affect the heart. Researchers hope to understand the link between brain and heart injury to help improve care for people who have had a brain bleed.
This trial collects blood, spinal fluid, urine, and stool samples from people who have had a specific type of stroke caused by a brain aneurysm. The goal is to look at these samples in detail to learn more about the condition and possibly find new ways to treat or predict outcomes.
This trial tests a pill called baricitinib to see if it helps people recover from lung injury after a brain bleed. It is for patients who need a breathing machine due to ARDS that started within a week of the bleed.
Hear when a new Subarachnoid Haemorrhage (SAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.